Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Strategies to Avoid the "Hemolyzed" Physical Examination.

Garibaldi BT, Russell SW.

JAMA Intern Med. 2019 Jul 1;179(7):1000. doi: 10.1001/jamainternmed.2019.1729. No abstract available.

PMID:
31260013
2.

Improving Observational Skills to Enhance the Clinical Examination.

Russell SW.

Med Clin North Am. 2018 May;102(3):495-507. doi: 10.1016/j.mcna.2017.12.011. Review.

PMID:
29650071
3.

The Other Sylvian Fissure: Exploring the Divide Between Traditional and Modern Bedside Rounds.

Russell SW, Garibaldi BT.

South Med J. 2016 Dec;109(12):747-749. No abstract available.

PMID:
27911965
4.

Evaluation of an advanced physical diagnosis course using consumer preferences methods: the nominal group technique.

Coker J, Castiglioni A, Kraemer RR, Massie FS, Morris JL, Rodriguez M, Russell SW, Shaneyfelt T, Willett LL, Estrada CA.

Am J Med Sci. 2014 Mar;347(3):199-205. doi: 10.1097/MAJ.0b013e3182831798.

PMID:
23552288
5.

PDA+: A Personal Digital Assistant for Obesity Treatment - an RCT testing the use of technology to enhance weight loss treatment for veterans.

Duncan JM, Janke EA, Kozak AT, Roehrig M, Russell SW, McFadden HG, Demott A, Pictor A, Hedeker D, Spring B.

BMC Public Health. 2011 Apr 11;11:223. doi: 10.1186/1471-2458-11-223.

6.

Make Better Choices (MBC): study design of a randomized controlled trial testing optimal technology-supported change in multiple diet and physical activity risk behaviors.

Spring B, Schneider K, McFadden HG, Vaughn J, Kozak AT, Smith M, Moller AC, Epstein L, Russell SW, DeMott A, Hedeker D.

BMC Public Health. 2010 Sep 29;10:586. doi: 10.1186/1471-2458-10-586.

7.

Serum-dependent potentiation of lipopolysaccharide-induced nitric oxide production is mediated by the events after the transcription of inducible type of nitric oxide synthase.

Zhang YH, Murphy WJ, Russell SW, Morrison DC, Koide N, Yoshida T, Yokochi T.

Cell Immunol. 2005 Mar;234(1):16-22.

PMID:
15936007
8.
11.

Activation of the iNOS gene promoter by Brn-3 POU family transcription factors is dependent upon the octamer motif in the promoter.

Gay RD, Dawson SJ, Murphy WJ, Russell SW, Latchman DS.

Biochim Biophys Acta. 1998 Dec 22;1443(3):315-22.

PMID:
9878805
13.

Analysis of expression and promoter function of the human inducible nitric oxide synthase gene in DLD-1 cells and monkey hepatocytes.

Laubach VE, Zhang CX, Russell SW, Murphy WJ, Sherman PA.

Biochim Biophys Acta. 1997 Apr 10;1351(3):287-95.

PMID:
9130592
14.
15.

Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice.

Chen LC, Pace JL, Russell SW, Morrison DC.

Infect Immun. 1996 Oct;64(10):4288-98.

16.

Efficacy of corneal eye shields in protecting patients' eyes from laser irradiation.

Russell SW, Dinehart SM, Davis I, Flock ST.

Dermatol Surg. 1996 Jul;22(7):613-6.

PMID:
8680783
17.

Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-gamma.

Zhang X, Laubach VE, Alley EW, Edwards KA, Sherman PA, Russell SW, Murphy WJ.

J Leukoc Biol. 1996 Apr;59(4):575-85.

PMID:
8613707
18.

Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages.

Miller L, Alley EW, Murphy WJ, Russell SW, Hunt JS.

J Leukoc Biol. 1996 Mar;59(3):442-50.

PMID:
8604025
19.

The application of ion beam analysis to calcium phosphate-based biomaterials.

Russell SW, Alford TL, Luptak KA, Pizziconi VB, Mayer JW.

J Biomed Mater Res. 1996 Feb;30(2):165-74.

PMID:
9019480
21.

Characterization of the 5' flanking region and gene encoding the mouse interferon-gamma receptor.

Raval P, Obici S, Russell SW, Murphy WJ.

Gene. 1995 Mar 10;154(2):219-23.

PMID:
7890167
22.

Ethnic differences in bone density in female South African nurses.

Daniels ED, Pettifor JM, Schnitzler CM, Russell SW, Patel DN.

J Bone Miner Res. 1995 Mar;10(3):359-67.

PMID:
7785456
23.

Cellular localization and hormonal regulation of inducible nitric oxide synthase in cycling mouse uterus.

Huang J, Roby KF, Pace JL, Russell SW, Hunt JS.

J Leukoc Biol. 1995 Jan;57(1):27-35.

PMID:
7530281
24.

Gestation-related expression of the interferon-gamma receptor gene in mouse uterine and embryonic hematopoietic cells.

Chen HL, Kamath R, Pace JL, Russell SW, Hunt JS.

J Leukoc Biol. 1994 May;55(5):617-25.

PMID:
8182339
25.
27.

Myeloproliferation in long-term plasmacytoma-regressor mice.

Sagi-Assif O, Douer D, Shaked N, Russell SW, Witz IP.

Int J Cancer. 1994 Jan 15;56(2):208-13.

PMID:
8314303
28.

Necessity and sufficiency of beta interferon for nitric oxide production in mouse peritoneal macrophages.

Zhang X, Alley EW, Russell SW, Morrison DC.

Infect Immun. 1994 Jan;62(1):33-40.

29.

Participation of IFN-gamma in the pathogenesis of LPS lethality.

Bucklin SE, Russell SW, Morrison DC.

Prog Clin Biol Res. 1994;388:399-406. No abstract available.

PMID:
7831371
30.

Binding site on the murine IFN-gamma receptor for IFN-gamma has been identified using the synthetic peptide approach.

VanVolkenburg MA, Griggs ND, Jarpe MA, Pace JL, Russell SW, Johnson HM.

J Immunol. 1993 Dec 1;151(11):6206-13.

PMID:
8245462
31.

Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide.

Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ.

Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9730-4.

32.

The mouse macrophage activation-associated marker protein, p71/73, is an inducible prostaglandin endoperoxide synthase (cyclooxygenase).

Phillips TA, Kujubu DA, MacKay RJ, Herschman HR, Russell SW, Pace JL.

J Leukoc Biol. 1993 Apr;53(4):411-9.

PMID:
8482922
34.

Regulation by transforming growth factor-beta 1 of expression and function of the receptor for IFN-gamma on mouse macrophages.

Pinson DM, LeClaire RD, Lorsbach RB, Parmely MJ, Russell SW.

J Immunol. 1992 Sep 15;149(6):2028-34.

PMID:
1387670
35.

The N-terminus and C-terminus of IFN-gamma are binding domains for cloned soluble IFN-gamma receptor.

Griggs ND, Jarpe MA, Pace JL, Russell SW, Johnson HM.

J Immunol. 1992 Jul 15;149(2):517-20.

PMID:
1385606
37.

Characterization and use of monoclonal and polyclonal antibodies against the mouse interferon-gamma receptor.

LeClaire RD, Basu M, Pinson DM, Redick ML, Hunt JS, Zavodny PJ, Pace JL, Russell SW.

J Leukoc Biol. 1992 May;51(5):507-16.

PMID:
1376354
38.

Stable expression of a secreted form of the mouse IFN-gamma receptor by rat cells.

Fernando LP, LeClaire RD, Obici S, Zavodny PJ, Russell SW, Pace JL.

J Immunol. 1991 Jul 15;147(2):541-7.

PMID:
1830066
39.

Activation-associated marker proteins: peptide mapping and their expression in macrophage cell lines.

Pinson DM, Phillips TA, Pace JL, MacKay RJ, Russell SW.

Biochem Biophys Res Commun. 1991 Apr 30;176(2):882-6. Erratum in: Biochem Biophys Res Commun 1991 Jun 14;177(2):895.

PMID:
1851008
40.

Induction of macrophage-mediated tumor cytotoxicity by a hamster monoclonal antibody with specificity for lipopolysaccharide receptor.

Chen TY, Bright SW, Pace JL, Russell SW, Morrison DC.

J Immunol. 1990 Jul 1;145(1):8-12.

PMID:
1694209
41.

Interferons exhibit temporally distinct regulation of two bovine macrophage Fc receptors.

Pontzer CH, Russell SW.

J Leukoc Biol. 1990 Mar;47(3):258-64.

PMID:
2106563
42.

A monoclonal antibody against the ligand binding site of the receptor for mouse interferon-gamma.

Basu M, Pace JL, Pinson DM, Russell SW.

J Interferon Res. 1989 Oct;9(5):551-62.

PMID:
2477471
43.

Culture of macrophages from bovine bone marrow.

Pontzer CH, Russell SW.

Vet Immunol Immunopathol. 1989 Jul;21(3-4):351-62.

PMID:
2678729
44.

Causal association of interferon-gamma with tumor regression.

Jarpe MA, Hayes MP, Russell JK, Johnson HM, Russell SW.

J Interferon Res. 1989 Apr;9(2):239-44.

PMID:
2497201
45.
46.

Purification and partial characterization of a receptor protein for mouse interferon gamma.

Basu M, Pace JL, Pinson DM, Hayes MP, Trotta PP, Russell SW.

Proc Natl Acad Sci U S A. 1988 Sep;85(17):6282-6.

47.

Enrichment and initial characterization of the solubilized receptor for mouse gamma interferon.

Hayes MP, Russell SW, Trotta PP, Basu M.

Biochem Biophys Res Commun. 1988 Feb 15;150(3):1096-105.

PMID:
2963631
48.

Protein phenotypes of mouse macrophages activated in vivo for tumor cell killing.

MacKay RJ, Russell SW.

J Leukoc Biol. 1987 Sep;42(3):213-21.

PMID:
3114400
49.

The effects of interferons on macrophages and their precursors.

Russell SW, Pace JL.

Vet Immunol Immunopathol. 1987 May;15(1-2):129-65. Review. No abstract available.

PMID:
2441513
50.

Comparison of five short-term assays that measure nonspecific cytotoxicity mediated to tumor cells by activated macrophages.

Russell SW, Pace JL, Varesio L, Akporiaye E, Blasi E, Celado A, Schreiber RD, Schultz RM, Stevenson AP, Stewart CC, et al.

J Leukoc Biol. 1986 Dec;40(6):801-13.

PMID:
3097225

Supplemental Content

Loading ...
Support Center